Acorda Therapeutics, Inc. financial data

Symbol
ACORQ on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
Two Blue Hill Plaza, Pearl River, NY
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 49.6 % -74.1%
Quick Ratio 11.9 % -67.3%
Return On Equity 486 %
Return On Assets -114 % -671%
Operating Margin -236 % -828%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.24M shares -94.9%
Entity Public Float 16.1M USD +42.9%
Common Stock, Value, Issued 1K USD -95.8%
Weighted Average Number of Shares Outstanding, Basic 1.24M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 1.24M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 116M USD -2.22%
Research and Development Expense 4.72M USD -14.1%
Costs and Expenses 389M USD +162%
Operating Income (Loss) -273M USD -807%
Nonoperating Income (Expense) -31.3M USD -11793%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -304M USD -920%
Income Tax Expense (Benefit) -41M USD -245%
Net Income (Loss) Attributable to Parent -263M USD -352%
Earnings Per Share, Basic -212 USD/shares -176%
Earnings Per Share, Diluted -212 USD/shares -176%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.36M USD -69.1%
Accounts Receivable, after Allowance for Credit Loss, Current 9.19M USD -0.02%
Inventory, Net 14.1M USD +4.86%
Other Assets, Current 2.45M USD -39.9%
Assets, Current 48.5M USD -28.8%
Property, Plant and Equipment, Net 1.89M USD -20.6%
Operating Lease, Right-of-Use Asset 3.94M USD -21.6%
Intangible Assets, Net (Excluding Goodwill) 22.3M USD -92.5%
Other Assets, Noncurrent 4.69M USD +213%
Assets 81.6M USD -78.2%
Accounts Payable, Current 9.93M USD +248%
Accrued Liabilities, Current 17.7M USD -34.6%
Liabilities, Current 224M USD +545%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 2.85M USD -29.8%
Other Liabilities, Noncurrent 8.04M USD -14.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 875K USD +21.7%
Retained Earnings (Accumulated Deficit) -1.22B USD -27.6%
Stockholders' Equity Attributable to Parent -186M USD -341%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -186M USD -341%
Liabilities and Equity 81.6M USD -78.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.2M USD -188%
Common Stock, Shares Authorized 3.08M shares -95%
Common Stock, Shares, Issued 1.24M shares -94.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.3M USD -193%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.3M USD -72.6%
Deferred Tax Assets, Valuation Allowance 131M USD +22.4%
Deferred Tax Assets, Gross 140M USD -6.59%
Operating Lease, Liability 4.45M USD -20.7%
Payments to Acquire Property, Plant, and Equipment 39K USD +39.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -263M USD -362%
Lessee, Operating Lease, Liability, to be Paid 5.04M USD -23.6%
Property, Plant and Equipment, Gross 7.66M USD -18.1%
Operating Lease, Liability, Current 1.6M USD +2.76%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.68M USD +2.76%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.63M USD +2.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -2.04M USD -890%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 594K USD -39.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 357K USD -78.7%
Deferred Tax Assets, Operating Loss Carryforwards 70M USD -6.13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 6.03M USD -3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 182K USD -49%
Operating Lease, Payments 397K USD +2.85%
Amortization of Intangible Assets 23.7M USD -22.9%
Depreciation, Depletion and Amortization 882K USD -88.9%
Deferred Tax Assets, Net of Valuation Allowance 9.22M USD -78.6%
Share-based Payment Arrangement, Expense 537K USD -50.4%
Interest Expense 32.4M USD +7.25%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%